140
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas

, , , &
Pages 427-433 | Received 13 Jan 2010, Accepted 11 Jun 2010, Published online: 03 Aug 2010

References

  • Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers–liposomes and microspheres–on the phagocytosis by macrophages. J Control Release, 79, 29–40.
  • Akhavein N, Oettinger CW, Gayakwad SG, Addo RT, Bejugam NK, Bauer JD, Do D, Pollock SH, D’souza MJ. (2009). Treatment of adjuvant arthritis using microencapsulated antisense NF-kappaB oligonucleotides. J Microencapsul, 26, 223–234.
  • Arifin DY, Lee LY, Wang CH. (2006). Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Deliv Rev, 58, 1274–1325.
  • Banga AK. (2006). Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, 2nd edn. Boca Raton, FL: CRC/Taylor & Francis.
  • Basarkar A, Devineni D, Palaniappan R, Singh J. (2007). Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm, 343, 247–254.
  • Bejugam NK, Uddin AN, Gayakwad SG, D’Souza MJ. (2008). Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul, 25, 577–583.
  • Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13, 123–133.
  • Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D’Souza MJ. (2009). Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. J Microencapsul, 26, 692–700.
  • Higuchi T. (1960). Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem, 11, 85–97.
  • Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50, 874–875.
  • Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52, 1145–1149.
  • Hunter RJ. (1981). Zeta Potential in Colloid Science: Principles and Applications. London; New York: Academic Press.
  • Jin Z. (2004). Evaluation of tumor suppression after treatment with microencapsulated lipo-polysaccharides. In: Department of Pharmaceutical Sciences. Atlanta: Mercer University.
  • Lehne G. (2000). P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets, 1, 85–99.
  • Liu Z, Ballinger JR, Rauth AM, Bendayan R, Wu XY. (2003). Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. J Pharm Pharmacol, 55, 1063–1073.
  • Mathiowitz E, Jacob JS, Jong YS, Carino GP, Chickering DE, Chaturvedi P, Santos CA, Vijayaraghavan K, Montgomery S, Bassett M, Morrell C. (1997). Biologically erodable microspheres as potential oral drug delivery systems. Nature, 386, 410–414.
  • Okada H, Toguchi H. (1995). Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst, 12, 1–99.
  • Uddin AN, Bejugam NK, Gayakwad SG, Akther P, D’Souza MJ. (2009). Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Target, 17, 553–560.
  • Zheng JH, Chen CT, Au JL, Wientjes MG. (2001). Time- and concentration-dependent penetration of doxorubicin in prostate tumors. AAPS PharmSci, 3, E15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.